Previous close | 6.85 |
Open | 6.75 |
Bid | 6.60 |
Ask | 6.80 |
Strike | 50.00 |
Expiry date | 2024-09-20 |
Day's range | 6.41 - 6.75 |
Contract range | N/A |
Volume | |
Open interest | 5.54k |
PRINCETON, N.J., May 06, 2024--U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 06, 2024--European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line....
It's easy to match the overall market return by buying an index fund. When you buy individual stocks, you can make...